Table 2.
Preimplant inflammatory characteristics.
| All cases | max tSOFA score < 11 | max tSOFA score ≥ 11 | P | ||
|---|---|---|---|---|---|
| (n = 53) | (Group A = 32) | Outcome + (group B = 8) | Outcome − (group C = 13) | ||
| TNF-α, pg/mL | 9.3 (5.2–12.1) | 6.9 (5.0–10.4) | 10.3 (2.6–16.3) | 9.7 (9.4–14.0) | 0.081 |
| IL-6, pg/mL | 9.8 (3.6–27.4) | 6.8 (3.0–24.1) | 17.8 (6.1–118.7) | 25.6 (9.6–63.4) | 0.067 |
| IL-8, pg/mL | 7.6 (5.2–13.6) | 7.7 (5.5–11.3) | 5.1 (3.7–14.4) | 13.1 (5.3–24.2) | 0.294 |
| C-reactive protein, mg/dL | 1.5 (0.5–3.9) | 1.2 (0.3–3.1) | 2.2 (0.8–13.1) | 2.2 (1.1–8.4) | 0.108 |
| IL-10, pg/mL | 1.8 (0–7.5) | 1.8 (0–8.0) | 1.7 (0–6.2) | 2.2 (0–14.4) | 0.824 |
| IL-1ra, pg/mL | 518 (311–1276) | 491 (295–840) | 785 (268–1955) | 828 (468–1898) | 0.137 |
| sICAM-1, pg/mL | 300 (224–433) | 291 (226–397) | 332 (220–676) | 323 (210–528) | 0.739 |
| sP-selectin/PLT, pg/106 | 288 (164–505) | 221 (173–476) | 410 (217–622) | 337 (122–537) | 0.742 |
| Neo/Cr ratio, μmol/mol | 290 (199–563) | 279 (181–457) | 317 (128–549) | 337 (240–698) | 0.422 |
Data are expressed as median and interquartile range (25th–75th).
IL: interleukin; Neo/Cr: neopterin levels normalized by urine creatinine levels; sICAM-1: soluble form of intercellular adhesion molecule type 1; sP-selectin/PLT: soluble platelet selectin normalized by platelet count; TNF: tumor necrosis factor; +: positive; −: negative.